For patients with kidney failure requiring hemodialysis treatment, sometimes the blood pressure will drop too low during dialysis. In an effort to prevent that from occurring, patients are frequently told to skip doses of their blood pressure medications. However, whether this actually prevents blood pressure drops during dialysis, and whether it may cause more uncontrolled high blood pressure is unknown. TAKE-HOLD will study the effect of taking or holding blood pressure medication on blood pressure for patients on hemodialysis.
High blood pressure (BP) is a major modifiable risk factor for cardiovascular disease, and upwards of 90% of patients with end- stage renal disease (ESRD) have high BP. Appropriate BP management, therefore, is a fundamental part of patient care in ESRD, yet the question of when best to take antihypertensive medications relative to the hemodialysis treatment session remains unanswered. Many patients on hemodialysis suffer from an abrupt fall in BP during the dialysis session (i.e., intradialytic hypotension \[IDH\]), a phenomenon that is associated with numerous adverse outcomes. In an attempt to minimize IDH, patients are often told to withhold antihypertensive medications prior to hemodialysis, and current guidelines suggest taking antihypertensive medications at night to minimize IDH. However, there are no data regarding the safety of these antihypertensive medication timing strategies, or whether these strategies are effective in reducing IDH.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
131
All participants will be told to take once daily antihypertensive medications at night. Timing of other antihypertensive medication administration will differ depending on whether the participant is randomized to the TAKE or HOLD arm.
Satellite Health Care
Menlo Park, California, United States
Satellite Health Care
San Carlos, California, United States
Intradialytic Hypotension
Number of participants with ≥30% of dialysis sessions with symptomatic or asymptomatic IDH.
Time frame: 4-week intervention period
Poorly controlled pre-dialysis blood pressure
Number of participants with ≥30% of dialysis sessions with pre-dialysis systolic BP \> 160 mm Hg
Time frame: 4-week intervention period
Dialysis Tolerability
Number of participants with ≥30% of dialysis sessions with post-dialysis weight \> prescribed dry weight or delivered length of dialysis \< prescribed length. We will also assess dialysis symptoms using the Dialysis Symptom Index.
Time frame: 4-week intervention period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.